CervoMed (CRVO) Stock: Buy, Sell, or Hold?
$1.80
+0.43 (+31.39%)
â˛
5d:
+15.38%
30d:
-20.7%
90d:
-38.57%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
47/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.60 â $2.80
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$15.00
+994.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.27 / $2.18
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CRVO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $1.80, which is considered slightly low relative to its 30-day fair value range of $1.60 to $2.80.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $2.18. The stock is showing strong short-term momentum, up 31.4% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.00 (+994.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $2.18. The stock is showing strong short-term momentum, up 31.4% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.00 (+994.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.60 -
$2.80
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Trading Range & Key Levels
30-Day Trading Range
$1.60 -
$2.80
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.27
Resistance Level
$2.18
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+31.4%)
- BULLISH: Trading 994.9% below Wall St target ($15.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.99
Wall Street Target
$15.00
(+994.9%)
Revenue Growth (YoY)
-99.6%
Share CRVO Analysis
Share this live CRVO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRVO)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Roth Capital maintains bullish stance on $CRVO with a price target of $7, urging investors to hold onto their shares in the face of bearish sentiment.
Key Retail Themes:
Price target
Bearish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 3:20 PM ET
Data refreshes hourly during market hours. Next update: 4:20 PM
Data refreshes hourly during market hours. Next update: 4:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRVO Research Pages
